Targeted ultrasound contrast agents for the disruption of alzheimer's plaques
Ended Project Grant Awarded Last action
- Award ID
- R43AG067894
- Recipient
-
Microvascular Therapeutics Inc. UEI ZA54X6LR5AS3
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $364,170
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date
- Originally
- Funding
-
- $379,835.00 Federal
- -$15,665.00 Non-federal
- Place of performance
- Tucson, AZ 85719, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$6 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | -$15,665 | $0 | |
| Amendment | -$15,665 | -$15,665 | |
| Original award | $411,171 | $0 |
Quick answers
Who received award R43AG067894?
R43AG067894 was awarded to Microvascular Therapeutics Inc. by National Institute on Aging (National Institutes of Health) on August 1, 2020.
How much is award R43AG067894 worth?
$364,170 has been obligated on R43AG067894: $379,835 in federal funding and -$15,665 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award